Lv0
0 积分 2022-10-14 加入
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
9小时前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
9小时前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
9小时前
已完结
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
2个月前
已完结
X versus XELOX versus PF in definitive concurrent chemoradiotherapy (DCRT) for local advanced squamous esophageal cancer (ESCC): Update from a multicenter, open-label, randomized III trial, CRTCOESC trial
2个月前
已关闭
Dedifferentiated parosteal osteosarcoma
3个月前
已关闭
Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2−) Breast Cancer
11个月前
已完结
The dynamic role of platelets in cancer progression and their therapeutic implications
11个月前
已完结
Inflammation: the incubator of the tumor microenvironment
11个月前
已完结
Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery
11个月前
已完结
皖公网安备34019202002308
